|
Market Closed -
Nasdaq
01:30:00 28/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 21.46 USD | +9.77% |
|
+6.19% | - |
| 14/08 | Attovia Therapeutics Insider Bought Shares Worth $10,285,000, According to a Recent SEC Filing | MT |
| 06/08 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to NASDAQ Composite Index | CI |
| 1 day | +9.77% | ||
| 1 week | +6.19% |
| 1 week | 18.85 |  | 21.96 |
| 1 month | 16.15 | | 24.32 |
| Current year | 16.15 | | 24.32 |
| 1 year | 16.15 | | 24.32 |
| 3 years | 16.15 | | 24.32 |
| 5 years | 16.15 | | 24.32 |
| 10 years | 16.15 | | 24.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hangjun Zhan
CTO | Chief Tech/Sci/R&D Officer | - | 16/12/2022 |
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2023 |
Tao Fu
CEO | Chief Executive Officer | 54 | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 01/06/2023 |
Tao Fu
BRD | Director/Board Member | 54 | 01/04/2023 |
James Topper
CHM | Chairman | 64 | 01/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/08/26 | Conversion | 18,65,710 | 4.3359% | |||
| 06/08/26 | Deep Track Capital LP
| Conversion | Company | 2,01,38,956 | 46.8032% | |
| 06/08/26 | Frazier Life Sciences Management LP
| Conversion | Company | 5,70,86,820 | 132.6705% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.77% | +6.19% | - | - | 92Cr | |
| +3.31% | -3.70% | +61.03% | +103.64% | 7.06TCr | |
| +1.09% | +2.51% | +49.34% | +93.39% | 6.61TCr | |
| -1.03% | +0.46% | +8.14% | -5.28% | 2.8TCr | |
| -2.41% | -2.95% | -9.77% | +455.82% | 2.65TCr | |
| +0.30% | -0.59% | +63.34% | +12.04% | 2.64TCr | |
| +1.02% | +6.43% | +269.42% | +420.34% | 2.04TCr | |
| +0.37% | +1.21% | +36.55% | -15.78% | 2.02TCr | |
| -2.76% | -5.11% | +12.44% | +526.38% | 1.6TCr | |
| -1.50% | +2.92% | +43.50% | +151.30% | 1.37TCr | |
| Average | +0.84% | +1.51% | +59.33% | +193.54% | 2.89TCr | |
| Weighted average by Cap. | +0.68% | +0.67% | +56.42% | +154.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.35 1.16 1.08 0.99 1.87 128.94 1.88 12.85 5.02 64.98 5.07 4.96 215.07 |
| Net income | -3.98Cr -3.42Cr -3.2Cr -2.93Cr -5.52Cr -380.13Cr -5.53Cr -38Cr -15Cr -191.58Cr -15Cr -15Cr -634.06Cr | -6.06Cr -5.2Cr -4.87Cr -4.46Cr -8.4Cr -579.03Cr -8.43Cr -58Cr -23Cr -291.83Cr -23Cr -22Cr -965.84Cr |
| Net Debt | - | - |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | $21.46 | +9.77% | 1,37,307 |
| 26/26/26 | $19.55 | +1.24% | 1,43,299 |
| 25/26/25 | $19.31 | -6.35% | 1,89,293 |
| 24/26/24 | $20.62 | -0.87% | 81,036 |
| 21/26/21 | $20.80 | +2.92% | 3,62,171 |
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
